Current and emerging therapies for managing hyperphagia and obesity in Prader‐Willi syndrome: A narrative review
出版年份 2019 全文链接
标题
Current and emerging therapies for managing hyperphagia and obesity in Prader‐Willi syndrome: A narrative review
作者
关键词
-
出版物
Obesity Reviews
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-12-31
DOI
10.1111/obr.12992
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ghrelin octanoylation by ghrelin O-acyltransferase: Unique protein biochemistry underlying metabolic signaling
- (2019) James L. Hougland BIOCHEMICAL SOCIETY TRANSACTIONS
- Hormonal and metabolic effects of carbohydrate restriction in children with Prader Willi syndrome
- (2019) Krystal A. Irizarry et al. CLINICAL ENDOCRINOLOGY
- Changes in Health-Related Outcomes in Youth With Obesity in Response to a Home-Based Parent-Led Physical Activity Program
- (2019) Daniela A. Rubin et al. JOURNAL OF ADOLESCENT HEALTH
- Physical exercise and Prader‐Willi syndrome: A systematic review
- (2019) Javier S. Morales et al. CLINICAL ENDOCRINOLOGY
- Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
- (2019) Arulkumar Nagappan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MetAP2 inhibition increases energy expenditure through direct action on brown adipocytes
- (2019) Huey-Jing Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
- (2019) Bernard Zinman et al. DIABETES CARE
- A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome
- (2019) Virginia Kimonis et al. PLoS One
- Functional group and stereochemical requirements for substrate binding by ghrelin O -acyltransferase revealed by unnatural amino acid incorporation
- (2018) Elizabeth R. Cleverdon et al. BIOORGANIC CHEMISTRY
- Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome
- (2018) Joseph Polex-Wolf et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study
- (2018) Merlin G Butler et al. JOURNAL OF MEDICAL GENETICS
- Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061
- (2018) Bryan F. Burkey et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Chronic diazoxide treatment decreases fat mass and improves endurance capacity in an obese mouse model of Prader-Willi syndrome
- (2018) Jocelyn M. Bischof et al. MOLECULAR GENETICS AND METABOLISM
- The Oxytocin Receptor: From Intracellular Signaling to Behavior
- (2018) Benjamin Jurek et al. PHYSIOLOGICAL REVIEWS
- High levels of caregiver burden in Prader-Willi syndrome
- (2018) Nathalie Kayadjanian et al. PLoS One
- AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial
- (2018) Soraya Allas et al. PLoS One
- Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach
- (2018) Bethany A. Falls et al. ACS Chemical Neuroscience
- Dietary intake in youth with prader-willi syndrome
- (2018) Michelle L. Mackenzie et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
- (2018) Christoffer Clemmensen et al. Nature Reviews Endocrinology
- Obesity management in Prader–Willi syndrome: current perspectives
- (2018) Antonino Crinò et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- The Use of Oxytocin to Improve Feeding and Social Skills in Infants With Prader–Willi Syndrome
- (2017) Maïthé Tauber et al. PEDIATRICS
- Cannabidiol: State of the art and new challenges for therapeutic applications
- (2017) Simona Pisanti et al. PHARMACOLOGY & THERAPEUTICS
- Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
- (2017) Tinh-Hai Collet et al. Molecular Metabolism
- A review of chemosensory perceptions, food preferences and food-related behaviours in subjects with Prader–Willi Syndrome
- (2016) Lorelei Martínez Michel et al. APPETITE
- Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist
- (2016) Jocelyn M Bischof et al. BRITISH JOURNAL OF PHARMACOLOGY
- Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial
- (2016) R.J. Kuppens et al. CLINICAL ENDOCRINOLOGY
- Safety, tolerability, pharmacokinetics and pharmacodynamics of AZP-531, a first-in-class analogue of unacylated ghrelin, in healthy and overweight/obese subjects and subjects with type 2 diabetes
- (2016) S. Allas et al. DIABETES OBESITY & METABOLISM
- Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials
- (2016) Karolin Bettge et al. DIABETES OBESITY & METABOLISM
- Prader-Willi syndrome and atypical submicroscopic 15q11-q13 deletions with or without imprinting defects
- (2016) Maaz Hassan et al. European Journal of Medical Genetics
- Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort
- (2016) H Vollbach et al. INTERNATIONAL JOURNAL OF OBESITY
- The octanoylated energy regulating hormone ghrelin: An expanded view of ghrelin’s biological interactions and avenues for controlling ghrelin signaling
- (2016) Elizabeth R. Cleverdon et al. MOLECULAR MEMBRANE BIOLOGY
- Melanocortin-4 receptor–regulated energy homeostasis
- (2016) Michael J Krashes et al. NATURE NEUROSCIENCE
- Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study
- (2016) Aayed R. Alqahtani et al. Surgery for Obesity and Related Diseases
- Growth hormone therapy for Prader–Willi syndrome: challenges and solutions
- (2016) Graziano Grugni et al. Therapeutics and Clinical Risk Management
- Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader–Willi syndrome
- (2016) Ibrahim Knani et al. Molecular Metabolism
- Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone
- (2015) Krystal A. Irizarry et al. CLINICAL ENDOCRINOLOGY
- Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists
- (2015) Sten Madsbad DIABETES OBESITY & METABOLISM
- Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial
- (2015) D. D. Kim et al. DIABETES OBESITY & METABOLISM
- Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice
- (2015) C. Clemmensen et al. EMBO Molecular Medicine
- Effects of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
- (2015) Feng Sun et al. Journal of Diabetes Research
- Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children
- (2015) Chenhong Zhang et al. EBioMedicine
- The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis
- (2015) Jessica E. Potts et al. PLoS One
- Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome
- (2014) Yuji Oto et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome
- (2014) Stewart L. Einfeld et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Highly restricted deletion of the SNORD116 region is implicated in Prader–Willi Syndrome
- (2014) Eric Bieth et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Liraglutide as a Potentially Useful Agent for Regulating Appetite in Diabetic Patients with Hypothalamic Hyperphagia and Obesity
- (2014) Takao Ando et al. INTERNAL MEDICINE
- Hyperphagia: Current concepts and future directions proceedings of the 2nd international conference on hyperphagia
- (2014) Steven B. Heymsfield et al. Obesity
- GLP-1 receptor agonists: a review of head-to-head clinical studies
- (2014) Jennifer M. Trujillo et al. Therapeutic Advances in Endocrinology and Metabolism
- Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity
- (2014) Amit Joharapurkar et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Long-term effects of recombinant human growth hormone therapy in children with Prader–Willi syndrome
- (2013) Peter M. Wolfgram et al. CURRENT OPINION IN PEDIATRICS
- GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases
- (2013) Flavius Zoicas et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Does des-acyl ghrelin improve glycemic control in obese diabetic subjects by decreasing acylated ghrelin levels?
- (2013) Behiye Özcan et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: Dopamine transporter occupancy as measured by PET
- (2013) Lieuwe Appel et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Inhibition of ghrelin O-acyltransferase attenuates food deprivation-induced increases in ingestive behavior
- (2013) Brett J.W. Teubner et al. HORMONES AND BEHAVIOR
- Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
- (2013) L van Bloemendaal et al. JOURNAL OF ENDOCRINOLOGY
- Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats
- (2013) Bo Hjorth Bentzen et al. Obesity
- Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women
- (2013) T. E. Hughes et al. Obesity
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus
- (2012) S. K. Thondam et al. CLINICAL ENDOCRINOLOGY
- Prader-Willi Syndrome: Obesity due to Genomic Imprinting
- (2012) Merlin G. Butler CURRENT GENOMICS
- Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques
- (2012) P. Kievit et al. DIABETES
- An overview of the pharmacokinetics, efficacy and safety of liraglutide
- (2012) Bruce Bode DIABETES RESEARCH AND CLINICAL PRACTICE
- The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome
- (2012) Miho Senda et al. ENDOCRINE JOURNAL
- MECHANISMS IN ENDOCRINOLOGY: Ghrelin: the differences between acyl- and des-acyl ghrelin
- (2012) Patric J D Delhanty et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Editorial comment: Oxytocin, vasopressin and social behavior
- (2012) Larry J. Young et al. HORMONES AND BEHAVIOR
- A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome
- (2012) J. L. Miller et al. JOURNAL OF HUMAN NUTRITION AND DIETETICS
- Ghrelin Level and Weight Loss After Laparoscopic Sleeve Gastrectomy and Gastric Mini-Bypass for Prader–Willi Syndrome in Chinese
- (2012) Anthony K. W. Fong et al. OBESITY SURGERY
- Nutritional phases in Prader-Willi syndrome
- (2011) Jennifer L. Miller et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability
- (2011) A. J. Garber DIABETES CARE
- Treating diabetes mellitus in Prader–Willi syndrome with Exenatide
- (2011) Ian W. Seetho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats
- (2011) Elsmarieke van de Giessen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of a Single Dose of Exenatide on Appetite, Gut Hormones, and Glucose Homeostasis in Adults with Prader-Willi Syndrome
- (2011) Lisa Sze et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- In adults with Prader–Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels
- (2011) Louise Purtell et al. NEUROPEPTIDES
- Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients
- (2011) Maïthe Tauber et al. Orphanet Journal of Rare Diseases
- Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists
- (2011) América A. Scopinho et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- Tesofensine, a Novel Triple Monoamine Reuptake Inhibitor, Induces Appetite Suppression by Indirect Stimulation of α1 Adrenoceptor and Dopamine D1 Receptor Pathways in the Diet-Induced Obese Rat
- (2010) Anne Marie D Axel et al. NEUROPSYCHOPHARMACOLOGY
- Motor problems in Prader–Willi syndrome: A systematic review on body composition and neuromuscular functioning
- (2010) Linda Reus et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Unacylated Ghrelin Rapidly Modulates Lipogenic and Insulin Signaling Pathway Gene Expression in Metabolically Active Tissues of GHSR Deleted Mice
- (2010) Patric J. D. Delhanty et al. PLoS One
- Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice
- (2010) T.-J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tesofensine – a novel potent weight loss medicine
- (2009) Sheila A Doggrell EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy and Safety of Long-Term Continuous Growth Hormone Treatment in Children with Prader-Willi Syndrome
- (2009) Roderick F. A. de Lind van Wijngaarden et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Critical Analysis of Bariatric Procedures in Prader-Willi Syndrome
- (2009) AO Scheimann et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Ghrelin Induces Abdominal Obesity Via GHS-R-Dependent Lipid Retention
- (2009) Jeffrey S. Davies et al. MOLECULAR ENDOCRINOLOGY
- Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development
- (2008) Andrea M. Haqq et al. CLINICAL ENDOCRINOLOGY
- Recommendations for the Diagnosis and Management of Prader-Willi Syndrome
- (2008) A. P. Goldstone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
- (2008) Arne Astrup et al. LANCET
- Oxytocin Deficiency Mediates Hyperphagic Obesity ofSim1Haploinsufficient Mice
- (2008) Bassil M. Kublaoui et al. MOLECULAR ENDOCRINOLOGY
- Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats
- (2008) Tobias Inhoff et al. PEPTIDES
- Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides
- (2008) J. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ghrelin octanoylation mediated by an orphan lipid transferase
- (2008) J. A. Gutierrez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started